检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]同济大学附属同济医院检验科,上海200065
出 处:《中华检验医学杂志》2016年第5期336-339,共4页Chinese Journal of Laboratory Medicine
基 金:National Natural Science Foundation of China Grants (81272603,81472179)国家自然科学基金
摘 要:肿瘤疾病的早期往往缺乏客观明确的诊断指标,给治疗工作带来很大困扰。如何在癌变的早期发现一些有价值的标志物或者特征性变化,是医学专家们亟需解决的重点难题。随着流式细胞术(FCM)的不断进步,FCM在肿瘤的癌前病变筛查、早期癌变的检出、化疗指导以及预后评估等各个方面发挥着越来越重要的作用。在个体化医疗及精准医疗的时代背景下,FCM在肿瘤标志物的检测、肿瘤干细胞(CSCs)分离筛选、循环肿瘤细胞(CTCs)的分离鉴定等方面的应用尤其值得期待。In the early stage of tumor, the diagnosis index of objective and definite is often deficient, which brings great trouble to the treatment How to find some valuable markers or characteristic changes in the early stage of cancer is the key problem to be solved by the medical experts. With the development of flow cytometry ( FCM), it is playing a more and more important role in precancerous lesion screening, early detection of cancer, chemotherapy guidance and prognosis assessment In personalized medicine and precise medical background, the application of FCM in tumor marker detection, cancer stem cells separation screening, isolation and identification of circulating tumor cells is especially worth looking forward to. ( Chin J Lab Med, 2016, 39: 336-339)
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28